Trials / Sponsors / Sinobioway Cell Therapy Co., Ltd.
Sinobioway Cell Therapy Co., Ltd.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma Lymphoma | N/A | 2018-04-10 |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma Lymphoma | Phase 1 | 2017-04-01 |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children Relapsed or Refractory Neuroblastoma | N/A | 2016-09-01 |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer Liver Neoplasms | N/A | 2015-11-14 |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemi Leukemia | N/A | 2015-11-01 |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer Stomach Neoplasms | N/A | 2015-11-01 |
| Unknown | Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma Lymphoma | N/A | 2015-07-02 |